Overall, the company remains a beneficiary of strong barriers to entry in the fluoro-chemical value chain and going forward, it should gain from the formidable expertise in delivering complex chemical intermediates for the pharmaceuticals industry
from Moneycontrol http://bit.ly/2XiEJHK
No comments:
Post a Comment